Bentham Science Logo

Track Your Manuscript:


Current Pharmaceutical Design

Volume 28, 46 Issues, 2022
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access

Contents

Current Pharmaceutical Design , Volume 15 - Number 14




Targeting Glutamatergic Signaling for the Development of Novel Therapeutics for Mood Disorders

, 15(14): 1595 - 1611

Rodrigo Machado-Vieira, Giacomo Salvadore, Lobna A. Ibrahim, Nancy Diaz-Granados and Carlos A. Zarate Jr.


DOI: 10.2174/138161209788168010


Opiates as Antidepressants

, 15(14): 1612 - 1622

Esther Berrocoso, Pilar Sanchez-Blazquez, Javier Garzon and Juan A. Mico


DOI: 10.2174/138161209788168100









Editor-in-Chief

Alessandro Antonelli
(14789 citations)
Department of Clinical and Experimental Medicine
Laboratory of Primary Human Cells
University of Pisa
Pisa
(Italy)
Biography
View Full Editorial Board

Nobel Laureate on Editorial Board

Andrew V. Schally
(USA)

COPE Compliant

Cope Logo

Advertisement

Jan-2022-banMechanisms-of-Metabolic-Disorders-(MMD)

Related Journals

Related eBooks

eBooks Catalog